Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This anesthetic protocol refers to a specific combination of drugs used for the induction and maintenance of general anesthesia in a clinical trial conducted by Ain Shams University. The regimen involves an induction phase using **fentanyl** (a potent opioid analgesic), **propofol** (an intravenous sedative-hypnotic), and **atracurium** (a non-depolarizing neuromuscular blocker). Maintenance of anesthesia is achieved through the administration of **isoflurane** (a volatile inhalational anesthetic) delivered in an oxygen and air mixture, supplemented with intermittent doses of atracurium to maintain muscle relaxation. This protocol was specifically evaluated in the context of middle ear surgery to facilitate controlled hypotension and optimize the surgical field.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fentanyl + propofol + atracurium + isoflurane.